MARKET

PBM

PBM

Psyence Biomedical Ltd.
NASDAQ
2.960
-0.220
-6.92%
Closed 19:11 02/11 EST
OPEN
3.190
PREV CLOSE
3.180
HIGH
3.229
LOW
2.920
VOLUME
62.59K
TURNOVER
35.22K
52 WEEK HIGH
74.94
52 WEEK LOW
2.535
MARKET CAP
3.03M
P/E (TTM)
-0.1491
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
Reuters · 16h ago
BUZZ-U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec
Reuters · 19h ago
BUZZ-Psyence BioMed gains on dispute settlement with shareholder KAOS Capital
Reuters · 21h ago
Psyence Biomedical announces settlement of shareholder litigation
TipRanks · 21h ago
*Psyence Biomedical: KAOS Agrees to Sell, or Cause to Be Sold, All Common Shares It Holds to a Third Party at $5/Shr >PBM
Dow Jones · 21h ago
*Psyence Biomedical to Pay an Aggregate Amount of $1.5M to KAOS >PBM
Dow Jones · 21h ago
*Psyence BioMed Announces Settlement of Shareholder Litigation From KAOS Capital
Dow Jones · 21h ago
Psyence Biomedical Settles Shareholder Litigation with KAOS Capital for $1.5 Million
Reuters · 21h ago
More
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBM stock methods without spending real money on the virtual paper trading platform.